YOUNG JOO JUNG: Open Payments
NPI 1235886987 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 42 payments from 7 companies in 2025. Trend: 2023 $394 · 2024 $871 · 2025 $792
Food & beverage: $693Education: $99
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 30 | $410 |
| Janssen Biotech, Inc. | 5 | $155 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: CABOMETYX, ERLEADA, RYBREVANT, LYNPARZA, Nubeqa, NINLARO, Xtandi.
Industry payments across TX — which companies pay providers there.
